Passed GDP inspection by TFDA for medicinal products. (Sep. 27th, 2021)
Passed GMP inspection by TFDA for packaging and labeling of medicinal products. (Sep. 15th, 2021)
US Patent No.US11,021,483 entitled Crystalline of camphorsulfonic acid salt of Rucaparib and method of preparing of tricyclic compounds, Rucaparib and crystalline of camphorsulfonic acid salt of Rucaparib was granted on June 1, 2021.
TW Patent No. I718533 entitled PREPARATION METHOD OF RIBOCICLIB AND ITS SALT AND CRYSTALLINE FORM THEREOF was granted on Feb 11, 2021.
Filed US DMF of Ferric Carboxymaltose (#035442, date of submission: Dec. 31, 2020)
Filed US DMF of Eribulin Mesylate (#035358, date of submission: Nov. 30, 2020)
US Patent No.US10766900B2 entitled Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof was granted on Sep 8, 2020.